“These findings suggest that semaglutide may prevent fatty liver disease from progressing to cirrhosis and can indeed reverse the course of the disease,” said Arun J. Sanyal, MD, study author ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared with placebo.

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment landscape for patients with metabolic dysfunction-associated ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic dysfunction-associated steatohepatitis (MASH). The interim results also reveal ...

“Semaglutide met the criteria for regulatory approval by showing improvement in liver histology, which makes it reasonably likely that it will prevent cirrhosis and related outcomes.

No liver abnormalities were recorded in these samples, and normal liver histology was confirmed when paraffin sections from the same resection were available. All control and FALD samples were ...

A 96-week clinical trial found that 300 mg of Vitamin E significantly improved liver histology and reduced inflammation in patients with MASH, with no major safety concerns reported.

CIRRHOSIS, the final stage of chronic liver diseases (CLDs), can be detected with non-invasive tests that are becoming increasingly available, and liver histology remains crucial for assessing ...